As of 2025-09-16, the EV/EBITDA ratio of Guardant Health Inc (GH) is -21.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GH's latest enterprise value is 7,319.24 mil USD. GH's TTM EBITDA according to its financial statements is -345.80 mil USD. Dividing these 2 quantities gives us the above GH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.8x - 12.2x | 10.4x |
| Forward P/E multiples | 8.2x - 15.6x | 10.5x |
| Fair Price | (28.25) - (37.73) | (32.81) |
| Upside | -151.6% - -168.9% | -159.9% |
| Date | EV/EBITDA |
| 2025-09-15 | -21.17 |
| 2025-09-12 | -21.20 |
| 2025-09-11 | -21.89 |
| 2025-09-10 | -21.81 |
| 2025-09-09 | -22.84 |
| 2025-09-08 | -23.10 |
| 2025-09-05 | -23.09 |
| 2025-09-04 | -23.54 |
| 2025-09-03 | -24.87 |
| 2025-09-02 | -25.39 |
| 2025-08-29 | -25.72 |
| 2025-08-28 | -24.66 |
| 2025-08-27 | -24.31 |
| 2025-08-26 | -24.28 |
| 2025-08-25 | -23.72 |
| 2025-08-22 | -23.55 |
| 2025-08-21 | -23.51 |
| 2025-08-20 | -22.50 |
| 2025-08-19 | -22.53 |
| 2025-08-18 | -22.85 |
| 2025-08-15 | -22.64 |
| 2025-08-14 | -23.18 |
| 2025-08-13 | -22.53 |
| 2025-08-12 | -21.28 |
| 2025-08-11 | -21.17 |
| 2025-08-08 | -20.96 |
| 2025-08-07 | -19.58 |
| 2025-08-06 | -17.49 |
| 2025-08-05 | -18.06 |
| 2025-08-04 | -17.34 |
| 2025-08-01 | -16.34 |
| 2025-07-31 | -16.19 |
| 2025-07-30 | -17.70 |
| 2025-07-29 | -17.03 |
| 2025-07-28 | -17.37 |
| 2025-07-25 | -17.43 |
| 2025-07-24 | -17.81 |
| 2025-07-23 | -17.80 |
| 2025-07-22 | -18.09 |
| 2025-07-21 | -17.87 |
| 2025-07-18 | -18.16 |
| 2025-07-17 | -18.46 |
| 2025-07-16 | -18.65 |
| 2025-07-15 | -18.75 |
| 2025-07-14 | -19.36 |
| 2025-07-11 | -19.53 |
| 2025-07-10 | -19.90 |
| 2025-07-09 | -19.81 |
| 2025-07-08 | -19.73 |
| 2025-07-07 | -19.27 |